Proto Labs, Inc.

Case Form

Find Out if You Potentially Qualify for a Financial Reward by filling out the form.












The submission of this form does not create an attorney-client relationship.

Investigation Details

On November 4, 2022, Proto reported Q3 results meeting the low end of its prior guidance and then announced lower than expected guidance for Q4 2024. Proto attributed it to “a decline in our injection molding revenue, predominantly due to the challenging macroeconomic climate” in addition to the negative impacts of foreign currency and “the closure of [Proto’s] Japan operation.” Analysts were skeptical of Proto’s explanation, pointing to increased competition as an alternate contributing factor for the decline.

Following this news, Proto’s stock price fell by $11.09 per share to close at $24.62 per share.